SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

Share Price is delayed by 15 minutes
Get Live Data
17.00    0.00 (0.00%)
Bid:
16.00
Ask:
18.00
Spread: 2.00 (12.50%)
Market Cap: £12.86m
FIPP Live PriceLast checked at - London Stock Exchange

Intraday Frontier Ip Share Chart

Board appointments

31 Mar 2014 07:00

RNS Number : 5183D
Frontier IP Group plc
31 March 2014
 



 

AIM: FIPP

 

Frontier IP Group plc

("Frontier IP" or "the Company")

 

Board changes

 

Frontier IP, which specialises in the commercialisation of university intellectual property, is pleased to announce two Board appointments, which both take immediate effect. James Fish has been appointed to the Company as Finance Director and Michael Bourne has been appointed to the Company as a Non-Executive Director.

 

James Fish, a chartered accountant, has over 25 years' experience in senior financial positions and a wide range of commercial experience including venture capital funded small/medium-sized enterprises and start-up companies. He was latterly interim Finance Director at The One Place Capital Limited, an online technology start-up. He qualified as a chartered accountant with KPMG and holds a degree in Accounting and Finance from Heriot Watt University, Edinburgh. James's appointment enables Marilyn Cole to step down as Finance Director and Company Secretary. James will also be appointed Company Secretary.

 

Michael Bourne has almost 30 years' experience in investment management and particular expertise in technology, life sciences and clean technology. He is currently Partner of Accretion Capital LLP and a Director of Cygna Negra Limited and Cygna Negra Malta Limited. He is also an Advisory Board Member of V2R, the US technology transfer venture company. Prior to these roles, in 1995, he founded asset management company, Reabourne Technology Investments Limited, where he was also Chief Investment Officer. For nine years until 2009, he was also a member of the techMARK Advisory Committee.

 

Neil Crabb, Chief Executive of Frontier IP, said,

 

"We are delightedto welcome Jim as Finance Director and Mike as a Non-executive Director. Their appointments strengthen our Board as we continue Frontier IP's development.

 

Jim brings over 25 years' experience as a senior finance professional and his involvement with start-up companies as well as venture capital funded SMEs is especially useful. Mike has substantial experience in investment management and his expertise in the clean energy and life sciences sectors also represents an excellent fit with Frontier IP's activities.

 

As well as welcoming Jim and Mike, I would also like to acknowledge Marilyn's significant contribution to Frontier IP during her time as Finance Director of the Company. She leaves with the Board's best wishes and grateful thanks."

 

The following information is required to be disclosed pursuant to paragraph (g) of Schedule 2 of the AIM Rules for Companies.

 

James Milne Fish, aged 56, is or has been a director or partner of the following companies during the previous five years:

 

Current Directorships / Partnerships:

Directorships / Partnerships held within the previous five years:

FD Support Limited

 

In addition, as an interim finance director, Mr Fish has undertaken in the previous five years a finance director role with The One Place Capital Limited, McLaren Software Group Limited and Photo Therapeutics Group Limited. Photo Therapeutics Group Limited entered into a Voluntary Members Liquidation in March 2009, after the return of funds to shareholders following a trade sale of the operating subsidiary.

 

Mr Fish is a member of the Institute of Chartered Accountants of Scotland.

 

Mr Fish currently has no beneficial interest in the share capital of the Company.

 

There are no other matters which are required to be announced with regard to the appointment of Mr Fish under paragraph (g) of Schedule 2 of the AIM Rules.

 

Michael Gerald Bourne, aged 55, is or has been a director or partner of the following companies during the previous five years:

 

Current Directorships / Partnerships:

Directorships / Partnerships held within the previous five years:

Accretion Capital LLP

MGB Technology Consulting Ltd

Coombe Wood Lawn Tennis Club Limited

Cygna Negra Limited

Cygna Negra Malta Limited

 

Mr Bourne currently has no beneficial interest in the share capital of the Company.

 

There are no other matters which are required to be announced with regard to the appointment of Mr Bourne under paragraph (g) of Schedule 2 of the AIM Rules.

 

 

Enquiries

 

Frontier IP Group Plc

0131 220 9491

Neil Crabb, Chief Executive

Company website: www.frontierip.co.uk

 

Cantor Fitzgerald Europe

(Nominated Adviser and Joint Broker)

020 7894 7000

Mark Percy / Catherine Leftley, Corporate Finance

David Banks / Paul Jewell, Corporate Broking

Peterhouse Corporate Finance Limited (Joint Broker)

020 7469 0935

Jon Levinson / Lucy Williams

KTZ Communications

020 3178 6378

Katie Tzouliadis / Deborah Walter

 

 

Notes to Editor:

 

Frontier IPspecialises in the commercialisation of Intellectual Property. It establishes partnerships with individual universities and research institutions to assist with their spin-out and licensing activities and helps to maximise the commercial value of technologies emerging from their research programmes. www.frontierip.co.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADVLFLZXFEBBK
Date   Source Headline
9th Dec 20212:33 pmRNSResult of AGM
29th Nov 20217:00 amRNSTVG - milestone in development of COVID-19 vaccine
9th Nov 20217:00 amRNSPosting of Annual Accounts and Notice of AGM
28th Oct 20217:00 amRNSDirectorate Change
28th Oct 20217:00 amRNSFinal Results
15th Oct 20217:00 amRNSPublication of newsletter
1st Oct 20217:59 amRNSPricing of IPO of Exscientia in the United States
30th Sep 20217:00 amRNSCamGraPhIC raises £1.6 million
27th Sep 20213:56 pmRNSUpdate on proposed IPO of Exscientia
24th Sep 20217:00 amRNSHolding(s) in Company
13th Sep 20217:00 amRNSExscientia - Statement filed for proposed IPO
8th Sep 20211:24 pmRNSExscientia enters $70M collaboration
8th Jul 20217:00 amRNSCamGraPhIC loan facility of up to £1.5 million
15th Jun 20217:00 amRNSPulsiv appoints Adam Westcott as CFO
14th Jun 20217:00 amRNSNandi Proteins appoints David Flower as CEO
11th Jun 20217:00 amRNSPublication of newsletter
24th May 20217:00 amRNSPulsiv complete £1.5m fundraising and appoints CEO
19th May 202111:53 amRNSExscientia collaboration with Bristol Myers Squibb
6th May 20217:00 amRNSThe Vaccine Group appoints Jeremy Salt as CEO
30th Apr 20211:58 pmRNSHolding(s) in Company
28th Apr 20217:01 amRNSTrading update
28th Apr 20217:00 amRNSExscientia Series D funding led by SoftBank
20th Apr 20217:00 amRNSHolding(s) in Company
24th Mar 20217:00 amRNSUnaudited Half Year Results
19th Mar 20217:00 amRNSFieldwork Robotics raises £675,000
18th Mar 20217:00 amRNSHolding(s) in Company
16th Mar 20217:00 amRNSAlusid - appoints David Taylor CBE to the Board
12th Mar 202112:27 pmRNSHolding(s) in Company
12th Mar 20217:00 amRNSHolding(s) in Company
11th Mar 20217:00 amRNSinSignals Neurotech receives EUR100,000 investment
9th Mar 20217:00 amRNSUN awards $250,000 grant to AquaInSilico
8th Mar 20219:05 amRNSSecond Price Monitoring Extn
8th Mar 20219:00 amRNSPrice Monitoring Extension
4th Mar 20217:30 amRNSExscientia completes $100 million Series C funding
22nd Feb 20217:00 amRNSPulsiv Solar raises £890,000
16th Feb 20217:00 amRNSPublication of newsletter
16th Feb 20217:00 amRNSHolding(s) in Company
1st Feb 20217:00 amRNSFrontier IP supports breakthrough technology
18th Jan 20217:00 amRNSHolding(s) in Company
15th Jan 20217:00 amRNSAppointment of Darren Winter
11th Jan 20217:00 amRNSPortfolio news – Elute Intelligence raises £250k
29th Dec 20201:44 pmRNSHolding(s) in Company
17th Dec 202012:30 pmRNSResult of AGM
1st Dec 20207:00 amRNSCambridge Raman participates in EUR 5m project
20th Nov 20207:00 amRNSPosting of Annual Report and Notice of AGM
16th Nov 20207:00 amRNSFrontier IP: recording of annual results webcast
16th Nov 20207:00 amRNSPortfolio news – Fieldwork SIF grant
13th Nov 20202:03 pmRNSHolding(s) in Company
10th Nov 20207:00 amRNSAlusid - £125,000 backing from UK Future Fund
9th Nov 20206:03 pmRNSDirectors’ Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.